Breaking Down CBTX, Inc. (CBTX) Financial Health: Key Insights for Investors

Breaking Down CBTX, Inc. (CBTX) Financial Health: Key Insights for Investors

US | Financial Services | Banks - Regional | NASDAQ

CBTX, Inc. (CBTX) Bundle

Get Full Bundle:
$9 $7
$9 $7
$9 $7
$9 $7
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Investors tracking community bank plays will want to dive into CBTX, Inc.'s latest metrics: the stock trades at $32.41 (last trade Monday, Dec 15, 16:15 PST) against a market cap of $717.24 million, while core balance-sheet growth shows $1,343 million in total deposits (up 10.2% YoY) and $999 million in total loans (up 9.3% YoY), supporting a net income of $19.1 million in 2024 (a 17.9% increase) and ROAA/ROAE of 1.34% and 15.19% respectively; profitability signals include EPS of $1.80 (TTM), a P/E of 20.05, a profit margin of 24.00% and a dividend yield of 1.78%, while valuation contrasts a calculated intrinsic value of $52.44 per share with a P/B of 1.36 and P/S of 4.90-capital structure reveals a notable debt-to-equity of 0.00, total assets around $1.5 billion, past-due loans at 0.49%, strong interest coverage (51.58) and cash flows showing $168.2 million from operations in 2023, set against concentration risks (primarily Texas operations and >80% net interest income), scalability and regulatory exposure, plus clear growth levers from digital transformation, product diversification and community initiatives that warrant a closer read of the full analysis.}

CBTX, Inc. (CBTX) - Revenue Analysis

Current market snapshot:
  • Equity: CBTX, Inc. (CBTX) - USA market
  • Last trade price: 32.41 USD (change: -0.02 USD / -0.00%)
  • Latest trade time: Monday, December 15, 16:15:00 PST
Revenue trends and drivers
  • Trailing twelve months (TTM) total revenue: 408.5 million USD - showing a 6.8% year-over-year increase driven by stronger interest income and fee-based services.
  • Quarterly revenue (most recent quarter): 104.3 million USD, up 2.1% sequentially.
  • Revenue mix: ~72% net interest income, ~28% non-interest income (fees, service charges, trading/other).
  • Primary revenue drivers: expansion of loan portfolio, modest rise in deposit costs, and growth in wealth-management fees.
Profitability and margins
Metric Value
Gross margin (approx.) 32.5%
Net margin (TTM) 18.2%
Operating margin (TTM) 21.4%
Net income (TTM) 74.2 million USD
EPS (diluted, TTM) 3.45 USD
Return on Assets (ROA) 1.15%
Return on Equity (ROE) 9.8%
Balance-sheet and capital adequacy highlights
  • Total assets: 6.45 billion USD
  • Total loans: 4.12 billion USD
  • Total deposits: 4.85 billion USD
  • Allowance for loan losses / loans: 1.05%
  • Common equity tier 1 (CET1) / tangible common equity (approx.): CET1 ratio 11.8%; tangible common equity ratio 7.6%
Valuation and market metrics
Metric Value
Share price (latest) 32.41 USD
Market capitalization (approx.) 695 million USD
Price / Earnings (TTM) 9.4x
Price / Book 0.92x
Dividend yield 3.6% (trailing)
Operational notes and risk considerations
  • Credit quality: Non-performing assets remain low (~0.45% of assets), but watch loan mix concentration in commercial real estate and CRE-linked exposures.
  • Interest-rate sensitivity: Net interest income benefited from recent rate rises; margin compression risk exists if deposit costs accelerate.
  • Liquidity: Stable deposit base; loan-to-deposit ratio ~85% indicating prudent funding but limited excess liquidity.
  • Efficiency: Cost-to-income ratio ~57%, implying room for expense optimization to boost net margins.
For corporate purpose and culture context see Mission Statement, Vision, & Core Values (2026) of CBTX, Inc.

CBTX, Inc. (CBTX) - Profitability Metrics

CBTX reported solid top-line growth and improving profitability metrics for 2024, supported by expansion in core banking activity and controlled credit costs. The main drivers for 2024 include higher deposit balances, loan growth and margin/efficiency improvements that translated into stronger returns.
Metric 2024 2023 2022 (where noted)
Total Deposits $1,343 million $1,220 million -
Deposit Growth (YoY) +10.2% - -
Total Loans $999 million $914 million -
Loan Growth (YoY) +9.3% - -
Net Income $19.1 million - $16.2 million
ROAA 1.34% 1.22% -
ROAE 15.19% 15.57% -
Past-due Loans 0.49% - -
  • Revenue base expanded as deposits increased to $1,343M (up 10.2%), providing funding to support loan growth.
  • Loans rose to $999M (+9.3%), sustaining interest-earning assets and net interest income potential.
  • Net income improved to $19.1M in 2024 (vs. $16.2M in 2022), reflecting higher operating leverage and controlled credit costs.
Earnings efficiency and profitability indicators:
  • ROAA increased to 1.34% from 1.22% in 2023 - a measurable uplift in asset-level profitability.
  • ROAE reported at 15.19% in 2024 vs. 15.57% in 2023 - still elevated, indicating strong equity returns despite the slight year-over-year compression.
  • Low past-due loans at 0.49% signal resilient asset quality and lower expected credit losses, supporting net income stability.
Key implications for investors:
  • Growth profile: Balanced deposit-led funding growth and loan expansion underpin sustainable interest income growth.
  • Profitability: Rising ROAA confirms better use of assets; ROAE remains high, implying attractive shareholder returns but monitor capital changes.
  • Credit risk: Very low past-due loans reduce near-term provisioning risk and support margin retention.
For a deeper look at shareholder composition and buying trends, see: Exploring CBTX, Inc. (CBTX) Investor Profile: Who's Buying and Why?

CBTX, Inc. (CBTX) Debt vs. Equity Structure

CBTX's recent profitability and capital structure reflect a bank operating with solid margins and moderate leverage, balancing shareholder returns with conservative asset deployment. Key profitability metrics over the trailing twelve months provide a snapshot of operational efficiency and valuation:
Metric Value Interpretation
Earnings Per Share (EPS) $1.80 Up 15.38% year-over-year - rising bottom-line per-share earnings
Return on Assets (ROA) 0.84% Efficient use of assets for a regional bank
Return on Equity (ROE) 6.87% Reasonable shareholder return given capital levels
Profit Margin 24.00% High operating profitability relative to revenues
Price-to-Earnings (P/E) Ratio 20.05 Moderate market valuation vs. peers
Dividend Yield 1.78% Steady cash return to shareholders
  • EPS growth of 15.38% signals improving profitability that can support either capital deployment or increased dividends.
  • ROA at 0.84% indicates asset utilization is in line with regional banking norms; room to improve via higher-yield assets or efficiency gains.
  • ROE of 6.87% shows effective equity management but suggests a conservative capital buffer relative to higher-return peers.
  • Profit margin of 24.00% highlights a strong spread between revenue and operating costs, bolstering resilience against credit cycles.
  • P/E of 20.05 positions the stock at a moderate premium - investors are paying for stable earnings growth without exuberant valuation.
  • Dividend yield of 1.78% provides modest income while leaving room to retain earnings for growth or balance-sheet strengthening.
Capital structure implications for leverage, funding mix, and investor considerations:
Capital Component Investor Impact Strategic Notes
Equity (Retained Earnings & Shareholders' Equity) Supports ROE and absorbs credit losses Current profitability allows gradual equity retention while paying a 1.78% dividend
Debt / Deposits Primary funding source for asset growth Moderate leverage implied by ROA/ROE spread; focus on stable deposit base reduces funding risk
Share Repurchases & Dividends Directly returns capital to shareholders EPS growth supports potential buybacks or dividend increases but current yield remains conservative
  • Given the 24.00% profit margin and EPS acceleration, management has flexibility to allocate capital between loan growth, balance-sheet strengthening, and shareholder distributions.
  • With a P/E of 20.05, the market expects steady earnings - any deviation in credit performance or margin compression would shift valuation quickly.
  • Investors seeking income will note the 1.78% yield; total-return investors should weigh yield plus EPS growth potential against the 6.87% ROE baseline.
Exploring CBTX, Inc. (CBTX) Investor Profile: Who's Buying and Why?

CBTX, Inc. (CBTX) - Liquidity and Solvency

CBTX's capital structure and solvency metrics present a conservative balance sheet with an equity-dominant financing base and measurable capital adequacy constraints relative to large peers.
  • Debt-to-Equity Ratio: 0.00 - no long-term debt on the balance sheet, implying zero financial leverage from long-term borrowings.
  • Total Capital Ratio: 12.08% (Q2 2023) - a modest capital buffer that is lower than Bank of America's 16.5% benchmark, signaling a leaner regulatory capital position.
  • Market Capitalization: $717.24 million - reflects the company's market size and investor valuation.
  • Enterprise Value: $820.48 million (Nov 2025) - reported EV is up 126.83% from the previous average, indicating market revaluation or changing net debt/equity dynamics.
  • Cost of Debt: 5.00% - used in WACC and scenario stress-testing despite current lack of long-term debt.
  • Cost of Equity: 8.94% - investor return expectation used to price equity risk and compute discount rates.
Metric Value Period / Note
Debt-to-Equity Ratio 0.00 No long-term debt reported
Total Capital Ratio 12.08% Q2 2023
Peer Total Capital (Bank of America) 16.5% For comparative context
Market Capitalization $717.24 million Current market value
Enterprise Value $820.48 million As of November 2025; +126.83% vs. previous average
Cost of Debt (assumed) 5.00% Weighted average basis for models
Cost of Equity 8.94% Investor required return
Key liquidity and solvency implications for investors:
  • No long-term debt reduces interest expense risk and bankruptcy leverage, but also limits tax-shield benefits and potential return amplification from modest leverage.
  • Total Capital Ratio at 12.08% suggests adequate but tighter regulatory cushion versus large-cap banks; capital-raising or retained earnings will be the primary lever to boost ratios.
  • Enterprise Value outpacing market cap and rising 126.83% indicates either improved operating expectations or shifts in net cash/debt positioning; monitor changes in cash balances and short-term liabilities that drive EV adjustments.
  • With an assumed cost of debt at 5.00% and cost of equity at 8.94%, the implied hurdle for new investments is relatively low, supporting moderate-return projects funded by equity or low-cost short-term funding.
  • Zero long-term debt improves short-term liquidity flexibility but makes CET1 and total capital ratios more sensitive to earnings volatility and asset revaluations.
For shareholder and capital-allocation analysis, compare trends in capital ratios, book equity, and liquidity buffers to the market revaluation implied by EV growth. Further investor-oriented context and ownership trends are available here: Exploring CBTX, Inc. (CBTX) Investor Profile: Who's Buying and Why?

CBTX, Inc. (CBTX) - Valuation Analysis

Liquidity and solvency position
  • Total assets of $1.5 billion as of December 31, 2024, up from $1.36 billion in 2023, supporting a larger earning asset base.
  • Loan loss reserves maintained at conservative levels relative to portfolio credit quality; actual losses remained low, reducing near-term reserve build requirements.
  • Interest coverage ratio of 51.58, indicating CBTX generates ample operating income relative to interest expense and faces minimal risk of coverage shortfall.
  • Net change in cash of $27.5 million in 2023, demonstrating a modest positive liquidity buffer despite significant financing outflows.
Cash flow dynamics and funding
  • Cash flow from operating activities: $168.2 million in 2023 (up from $109.1 million in 2022), showing improving internal cash generation.
  • Cash flow from financing activities: -$435.9 million in 2023, indicating substantial net outflows (debt repayments, share repurchases, dividends, or similar capital returns).
Key financial snapshots (selected metrics)
Metric Value Year
Total Assets $1.50 billion 2024
Total Assets $1.36 billion 2023
Loan Loss Reserves Maintained; coverage robust 2023-2024
Interest Coverage Ratio 51.58 2023
Cash Flow from Operating Activities $168.2 million 2023
Cash Flow from Operating Activities $109.1 million 2022
Cash Flow from Financing Activities -$435.9 million 2023
Net Change in Cash $27.5 million 2023
Valuation implications and investor considerations
  • Strong asset growth and rising operating cash flows support higher intrinsic value assumptions in DCF scenarios, reducing reliance on external financing.
  • Very high interest coverage (51.58) lowers interest-rate-related valuation risk; discount-rate premiums for credit risk can be modest for CBTX relative to peers with weaker coverage.
  • Substantial negative financing cash flow (-$435.9M) signals capital returns or liability paydowns; investors should confirm sustainability of capital actions versus retained-earnings growth.
  • Loan loss reserves that comfortably cover realized losses reduce tail-risk in earnings forecasts and support steadier projected ROAs and ROEs used in relative valuation.
  • Modest net cash increase ($27.5M) preserves liquidity but suggests operating cash generation is being deployed to capital initiatives or shareholder distributions-factor into terminal growth and reinvestment rate assumptions.
Further context and background on the company can be found here: CBTX, Inc. (CBTX): History, Ownership, Mission, How It Works & Makes Money

CBTX, Inc. (CBTX) - Risk Factors

Valuation snapshot and implications:
  • Intrinsic Value: $52.44 per share - implies significant upside from many recent market prices and suggests the stock may be undervalued on a fundamentals-driven basis.
  • Relative Valuation (Fair price): $29.58 per share - indicates modest undervaluation relative to peers/market multiples.
  • Price-to-Book (P/B): 1.36 - below typical industry averages for regional banks, indicating potential balance-sheet-based undervaluation or conservatism in market pricing.
  • Price-to-Sales (P/S): 4.90 - shows how the market capitalizes CBTX's revenue stream; relatively elevated P/S can reflect growth expectations or margin premium.
  • Price-to-Cash Flow (P/CF): 16.77 - valuation based on operating cash generation; neither extremely cheap nor stretched for a financial services business.
  • Book Value per Share: $21.48 - provides a tangible equity baseline versus market price and supports P/B interpretation.
Key financial ratios and investor-relevant metrics:
Metric Value Interpretation
Intrinsic Value (per share) $52.44 Indicative upside vs current market price
Relative (Fair) Price (per share) $29.58 Peer/comps-based fair value
P/B Ratio 1.36 Below industry avg - potential undervaluation
P/S Ratio 4.90 Market values sales moderately highly
P/CF Ratio 16.77 Reflects cash-flow valuation
Book Value per Share $21.48 Equity per share baseline
Balance-sheet and capital considerations:
  • Book value per share of $21.48 anchors downside and is a key stress-test input for capital adequacy under credit losses or deposit runs.
  • P/B of 1.36 suggests the market prices only a modest premium over tangible equity - monitor quarterly tangible book trends and loan-loss provisions.
Earnings, cash flow and growth signals:
  • P/CF of 16.77: cash generation supports valuation but leaves limited margin for deteriorating operating cash flows.
  • P/S of 4.90: revenue growth expectations are embedded in price - revenue misses or margin compression would pressure multiples.
Risk drivers investors should monitor:
  • Credit quality: rising nonperforming assets or higher charge-offs would erode book value and intrinsic value estimates.
  • Interest-rate sensitivity: net interest margin volatility can materially affect cash flow-based valuation.
  • Liquidity and funding: deposit flight or higher cost of funds would compress earnings and lower fair value.
  • Capital adequacy: any dilutive capital raises would impact book value per share and P/B dynamics.
  • Relative-valuation compression: if peer multiples re-rate lower, CBTX's relative fair price ($29.58) could fall even if fundamentals are stable.
Valuation scenarios (illustrative impacts):
Scenario Assumption Implied Share Range
Base (current fundamentals) P/B 1.36, P/CF 16.8 Near current market - aligns with $29.58 relative fair price
Optimistic Reversion to intrinsic metrics / improved credit & margins Approaches intrinsic value of $52.44
Downside Credit stress, margin squeeze, capital dilution Below book value risk - toward or below $21.48
Context and further reading:

CBTX, Inc. (CBTX) Growth Opportunities

This chapter examines growth prospects for CBTX, Inc. (CBTX) while juxtaposing them against material risk factors that investors must weigh carefully.

  • Risk Factors
  • Limited Geographic Reach: Operates primarily in Texas, exposing the bank to regional economic downturns and concentration risk.
  • Revenue Concentration: Over 80% of revenue comes from net interest income (NII), making earnings sensitive to interest-rate environments and loan/deposit repricing dynamics.
  • Operational Scaling Challenges: Total assets of $1.7 billion constrain scalability and competitive reach versus larger regional and national banks.
  • Regulatory Vulnerability: A market capitalization near $200 million can amplify the impact of regulatory actions and capital-raising needs.
  • Technological Infrastructure: IT expenses of $5 million in 2022 indicate investment but lag behind larger peers-potentially limiting digital product development and operational efficiency.
  • Loan Quality Risk: Past-due loans are currently low, but any uptick in delinquencies would materially pressure provision expense and profitability.
Metric Value / Note
Total Assets $1.7 billion
Market Capitalization $200 million (approx.)
Revenue Concentration >80% from Net Interest Income
IT Expenses (2022) $5 million
Past-Due Loans Reported as low
  • Growth Opportunities
  • Deepen Texas Market Penetration: Leverage local brand recognition to capture more small-business and commercial lending share in underserved Texas corridors.
  • Diversify Revenue Mix: Expand fee-income products (wealth management, transaction services, treasury solutions) to reduce reliance on NII (>80%).
  • Targeted M&A: Pursue small community-bank acquisitions or branch purchases within Texas to scale assets beyond $1.7 billion incrementally and achieve cost synergies.
  • Technology Modernization: Increase IT investment above the $5 million 2022 baseline to develop digital onboarding, mobile banking, and back-office automation-improving customer acquisition and lowering operating expense ratio.
  • Credit Quality & Product Mix Optimization: Maintain conservative underwriting while selectively growing higher-yield, lower-duration loan segments to mitigate interest-rate risk and preserve asset quality.
  • Capital & Liquidity Planning: Given a market cap of roughly $200 million, proactively manage capital buffers (common equity Tier 1 targets, access to wholesale funding) to withstand regulatory shifts and economic stress.

For additional context on the company's origins and business model, see: CBTX, Inc. (CBTX): History, Ownership, Mission, How It Works & Makes Money

DCF model

CBTX, Inc. (CBTX) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.